Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes

被引：0
|
作者：
Pamela C. Heaton
Vibha C. A. Desai
Christina M. L. Kelton
Swapnil N. Rajpathak
机构：
[1] University of Cincinnati Academic Health Center,Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy
[2] HealthCore,Carl H. Lindner College of Business
[3] University of Cincinnati,undefined
[4] US Outcomes Research,undefined
[5] Merck & Co.,undefined
[6] Inc.,undefined
来源：
BMC Endocrine Disorders | / 16卷
关键词：
Sulfonylureas; Oral antihyperglycemic agents; Type 2 diabetes; Hospital readmissions;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin
    J. M. M. Evans
    S. A. Ogston
    A. Emslie-Smith
    A. D. Morris
    Diabetologia, 2006, 49
  • [42] Association between hypoglycemia risk and hemoglobin A1C in patients with type 2 diabetes mellitus
    Yu, Shengsheng
    Fu, Alex Z.
    Engel, Samuel S.
    Shankar, R. Ravi
    Radican, Larry
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1409 - 1416
  • [43] Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
    Dabrowski, Mariusz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 18
  • [44] Reducing the risk of readmission and death after hospital discharge using a predictive model
    Luz Marques, Ma
    Perez, Itziar
    Jose Aurrekoetxea, Juan
    Berraondo, Inaki
    Eugenia Alkiza, Maria
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2018, 18
  • [45] The Readmission Risk Flag: Using the Electronic Health Record to Automatically Identify Patients at Risk for 30-Day Readmission
    Baillie, Charles A.
    VanZandbergen, Christine
    Tait, Gordon
    Hanish, Asaf
    Leas, Brian
    French, Benjamin
    Hanson, C. William
    Behta, Maryam
    Umscheid, Craig A.
    JOURNAL OF HOSPITAL MEDICINE, 2013, 8 (12) : 689 - 695
  • [46] Predictive modeling of 30-day readmission risk of diabetes patients by logistic regression, artificial neural network, and EasyEnsemble
    Xiang, Xiayu
    Liu, Chuanyi
    Zhang, Yanchun
    Xiang, Wei
    Fang, Binxing
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2021, 14 (09) : 417 - 428
  • [47] Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study
    Gonzalez, Claudio
    Monti, Cyntia
    Pinzon, Adolfo
    Monsanto, Homero
    Ejzykowicz, Flavia
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 (10): : 592 - 602
  • [48] The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy A retrospective analysis
    Pantalone, Kevin M.
    Kattan, Michael W.
    Yu, Changhong
    Wells, Brian J.
    Arrigain, Susana
    Jain, Anil
    Atreja, Ashish
    Zimmerman, Robert S.
    DIABETES CARE, 2010, 33 (06) : 1224 - 1229
  • [49] Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureas
    Iglay, Kristy
    Qiu, Ying
    Fan, Chun-Po Steve
    Li, Zhiyi
    Tang, Jackson
    Laires, Pedro
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (09) : 1567 - 1575
  • [50] Evaluation of the Yale New Haven Readmission Risk Score for Pneumonia in a General Hospital Population
    Schaefer, Gabrielle
    El-Kareh, Robert
    Quartarolo, Jennifer
    Seymann, Gregory
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (09) : 1107 - +
12345